Furthermore, low dosage of ibrutinib, IC50 around10 nM, showed sufficient blockage of BTK autophosphorylation, as well as its downstream signaling targets PLCγ and ERK in cultured B cell lymphoma DOHH2 cells [49]. The gene discussed is BTK; the disease is B-cell non-Hodgkin lymphoma.